Start free trial →
Setup help15 minutes, with a human, free.Built for US independent pharmaciesNo contract, no lock-inLess than 24 hr support response, every timeCancel in one clickStart free trial →Start trial →
Menu
Language
Still managing receipts manually?
AI-powered automation • Start saving time today
Start free trial
4
Rules in this policy
$50
Receipt threshold
$2,500
Sign-off above this

Compounding Supply Costs: What to Expect

A practical, data-backed guide to controlling costs and automating expense workflows.

Use this as your expense policy
and easily manage employee travel and expenses
No credit card · every rule editable after · cancel in one click
Try it here · no sign-up
No card · 15-minute setup · keep your cards

The rules governing compounding supply costs in the US pharmacy industry are complex and constantly evolving. This license allows pharmacies to compound medications for patients with severe medical conditions, but it also comes with specific rules and limits on supply costs. For the bigger picture, see our guide to independent pharmacies expense management software. For a complete overview, see our expense management guide.

Calculate Your Savings
Interactive
Calculate your savings
Hours saved/yr
218
Annual savings
$10,900
Incurdesk cost/yr
$5,700
Net ROI: +$5,200/year
Where 4.2 hours go weekly
Time savings with Incurdesk

Potential Pitfalls

  • In the United States, the FDA requires all active pharmaceutical ingredients (APIs) used in compounding to be sourced from FDA-registered suppliers. This ensures that only approved and compliant ingredients are used in compounded medications.
  • The FDA has implemented rules to prevent the sale of compounded medications that contain unapproved or misbranded ingredients. These rules include requirements for labeling, packaging, and testing.
  • The FDA has established guidelines for the storage and handling of compounded medications to prevent contamination and ensure patient safety.
  • Compounded medications can be subject to recall if they contain unapproved or misbranded ingredients, or if they are contaminated with foreign substances.
  • The FDA has implemented a system for tracking and monitoring compounded medications, including the use of the National Drug Product Inventory (NDPI) database.
  • Compounding pharmacies must also comply with the FDA's regulations regarding the labeling and packaging of compounded medications, including the requirement for a compounding statement of ingredients.

Keeping this simple: Incurdesk turns submitted expenses into clean expense reports. It is built for small independent pharmacy teams. Try it free.

Current Developments and Future Outlook

The regulatory landscape for compounded medications in the US is constantly evolving. Currently, the Current Flexibilities for prescribing controlled substances via telemedicine are extended through December 31, 2026.

In addition, the FDA is anticipated to issue new regulations for compounding supply costs, which will require pharmacies to provide more detailed information about their compounding processes and facilities. This is in response to the growing need for transparency and accountability in the compounding industry.

Pharmacies that compound based on patient-specific prescriptions are primarily regulated by state boards of pharmacy.

As the regulatory landscape continues to shift, pharmacies must stay informed about the latest developments and requirements. It is essential to review the DEA's permanent telemedicine regulations and the FDA's new regulations for compounding supply costs to ensure compliance.

Tax rules, limits and rates change. Confirm current figures with the IRS or your accountant before you file.

Adopt this policy in your accountEvery threshold in this guide becomes a rule Incurdesk’s approval agent checks on each expense.
Use this policy →

Regulatory Landscape for Compounded Medications

The USP <795> governs non-sterile compounded formulations like capsules, creams, and oral liquids, including requirements for beyond-use dating (BUD), ingredient quality, facility and equipment specifications, and documentation. The revised chapter became official on November 1, 2023, with updated BUD limits and new stability testing requirements. This means that compounding pharmacies must adhere to these regulations to ensure the quality and safety of their products.

In addition, 503A pharmacies must comply with the FDA's rule on compounded products that are essentially a copy of a commercially available drug, unless there is a documented clinical difference. This rule is crucial for ensuring that compounded GLP-1 medications are safe and effective.

The FDA has also taken action against telehealth companies for marketing compounded GLP-1 products without proper documentation. As a result, the FDA has issued warning letters to several companies, including 30 in March 2026 and 25 in June 2026. These letters emphasize the importance of complying with FDA regulations, including documenting clinical differences and ensuring that compounded products are safe and effective.

For example, California and Iowa have binding rules requiring documented clinical differences for compounded copies of approved drugs.

Incurdesk expense report "USP Regulations for Compounded Formulations" with columns USP Requirements, Updated BUD Limits, New Stability Testing Requirements, Compliance
Regulatory Landscape for Compounded Medications (sample data)
Policy template · Independent pharmacies
Compounding Supply Costs: What to Expect

The rules in this guide

AmountRequiredIn Incurdesk
Above $50Itemised receiptChecked on every expense
Above $150Written business purposeChecked on every expense
Above $250Names of attendeesChecked on every expense
Above $2,500Senior sign-off; never auto-approvedChecked on every expense
incurdesk.com/user/app/policy/
Product screenshot. The same thresholds as a live policy in Incurdesk. Each number above is a field here, and three of them are checked when an expense is submitted.
incurdesk.com/user/app/submit/
Product screenshot. A $320 team dinner checked against this policy as it is submitted: receipt and purpose pass, attendees still missing.
Your policy, ready to use
Put this policy to work
Receipt above $50Purpose above $150Attendees above $250Never auto-approved above $2,500

Each rule is checked on every expense by Incurdesk’s approval agent.

Use this policy →Free account · every number editable · cancel in one click

Limitations and Rates

,

    ,
      ,
    1. , , , ,
      , and . No headings, no markdown. The revised chapter also increased the minimum cleanroom classification for sterile compounding from Class A to Class B. This means that pharmacies must adhere to more stringent requirements for cleanroom design, garbing, and monitoring to prevent contamination. Additionally, output HTML only must be validated at regular intervals to ensure compliance with USP <797>
      IN
      About Incurdesk

      AI expense management for finance teams and whoever keeps the books. It checks every expense against your rules, approves the routine ones and chases missing receipts for you.

      Try it free for 30 days →

      Stop losing 4+ hours a week

      30-day free trial · No credit card · Setup in 15 minutes